drugset / Trial / NCT02466373
Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is developed for assessing the pharmacodynamic and pharmacokinetic properties of intravenous (IV) clonidine in critically ill patients on the ICU, and to estimate the optimal dosing strategy for IV clonidine.
Timeline
- Start
- 2016-12
- Primary completion
- 2018-04-05
- Completion
- 2018-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | 600 ug | Intravenous |
| Subject | Clonidine | Other / unclassified | 1200 ug | Intravenous |
| Subject | Clonidine | Other / unclassified | 1800 ug | Intravenous |